Anavex Life Sciences Corp (AVXL)

[Anshu2]

Most answers are obvious — we are just hesitant to say it.

At this point, IMO, CM is mulling — what direction to go.

1. Should he wait for EMA low-probability approval for AD, or start a new expensive AD trial as FDA seems (my personal belief; not a fact) to have made amply clear.

2. He is likely thinking about a large Rett trial too.

I really believe — there is very low chance of approval from current trials.